• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人C1q与IgG和IgM的相互作用:再探讨

Interaction of human C1q with IgG and IgM: revisited.

作者信息

Gadjeva Mihaela G, Rouseva Marieta M, Zlatarova Alexandra S, Reid Kenneth B M, Kishore Uday, Kojouharova Mihaela S

机构信息

Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Biochemistry. 2008 Dec 9;47(49):13093-102. doi: 10.1021/bi801131h.

DOI:10.1021/bi801131h
PMID:19006321
Abstract

The first step of activation of the classical complement pathway involves the binding of the globular C1q domain (gC1q) to the antigen-bound IgG or IgM. To improve our understanding of the mechanism of interaction of gC1q with IgG and IgM, we compared the immunoglobulin binding properties of single-residue mutants of individual globular modules of A and C chains. We found that Lys(A200) and Lys(C170) are significant for binding with both immunoglobulins. In addition, two C1q-specific scFv antibodies known as potent inhibitors of C1q-IgG and -IgM interactions were used in the epitope mapping analysis. A set of important residues, which participate in the C1q epitopes for scFv, were identified: Lys(C170) for the scFv3(V) epitope and Arg(B108) and Arg(B109) for the scFv10(V) epitope. The ability of scFv3(V) and scFv10(V) to bind preformed C1q-IgG or C1q-IgM complexes differed: scFv3(V) retained its ability to bind C1q, while scFv10(V) lost it. Given the different locations of the epitopes and the varying abilities of both antibodies to bind C1q-IgG and C1q-IgM complexes, we found that residues from the apical surface of C1q [where the scFv3(V) epitope was located] were involved in the initial recognition of IgG and IgM, while Arg(B108) and Arg(B109) are able to interact during the initial recognition as well as during the final binding of immunoglobulins. The reported results provide the first experimental evidence supporting the notion that apical and equatorial surfaces of gC1q have consecutive involvement following the gC1q reorientation during the interaction with specific C1q ligands.

摘要

经典补体途径激活的第一步涉及球形C1q结构域(gC1q)与抗原结合的IgG或IgM的结合。为了更好地理解gC1q与IgG和IgM相互作用的机制,我们比较了A链和C链单个球形模块的单残基突变体的免疫球蛋白结合特性。我们发现,赖氨酸(A200)和赖氨酸(C170)对于与两种免疫球蛋白的结合都很重要。此外,两种已知为C1q-IgG和-IgM相互作用有效抑制剂的C1q特异性单链抗体片段(scFv)被用于表位作图分析。鉴定出了一组参与scFv的C1q表位的重要残基:scFv3(V)表位的赖氨酸(C170)以及scFv10(V)表位的精氨酸(B108)和精氨酸(B109)。scFv3(V)和scFv10(V)结合预先形成的C1q-IgG或C1q-IgM复合物的能力有所不同:scFv3(V)保留了其结合C1q的能力,而scFv10(V)则失去了这种能力。鉴于表位的不同位置以及两种抗体结合C1q-IgG和C1q-IgM复合物的能力各异,我们发现C1q顶端表面(scFv3(V)表位所在位置)的残基参与了对IgG和IgM的初始识别,而精氨酸(B108)和精氨酸(B109)在免疫球蛋白的初始识别以及最终结合过程中都能够相互作用。所报道的结果提供了首个实验证据,支持了在与特定C1q配体相互作用期间gC1q重新定向后,gC1q的顶端和赤道表面连续参与的观点。

相似文献

1
Interaction of human C1q with IgG and IgM: revisited.人C1q与IgG和IgM的相互作用:再探讨
Biochemistry. 2008 Dec 9;47(49):13093-102. doi: 10.1021/bi801131h.
2
Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.人C1q球状结构域上不同但重叠的IgG和IgM结合位点的存在。
Biochemistry. 2006 Aug 22;45(33):9979-88. doi: 10.1021/bi060539v.
3
Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants.重新研究 C1q 与 pentraxin 3 和 IgM 的相互作用:用重组 C1q 变体进行突变研究。
Front Immunol. 2019 Mar 14;10:461. doi: 10.3389/fimmu.2019.00461. eCollection 2019.
4
Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q.钙离子在人补体C1q球状结构域的静电稳定性及功能活性中的作用
Biochemistry. 2005 Nov 1;44(43):14097-109. doi: 10.1021/bi051186n.
5
New insights into the molecular mechanisms of classical complement activation.经典补体激活分子机制的新见解。
Mol Immunol. 2010 Aug;47(13):2154-60. doi: 10.1016/j.molimm.2010.05.011. Epub 2010 Jun 9.
6
Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.结构域交换的小鼠IgM/IgG2b杂交抗体表明Cμ2、Cμ3和Cμ4结构域在调节IgM与补体C1q相互作用中具有各自的作用。
J Immunol. 1997 Oct 1;159(7):3354-63.
7
Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.C反应蛋白通过C1q的胶原样区域进行结合和补体激活,以及抗C反应蛋白和C1q单克隆抗体对这些反应的抑制。
J Immunol. 1991 Apr 1;146(7):2324-30.
8
Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction.对人C1q A、B和C链重组球状区域的突变分析表明,精氨酸和组氨酸残基在C1q与IgG的相互作用中起重要作用。
J Immunol. 2004 Apr 1;172(7):4351-8. doi: 10.4049/jimmunol.172.7.4351.
9
Complement C1q-target proteins recognition is inhibited by electric moment effectors.补体C1q靶向蛋白识别受电矩效应器抑制。
J Mol Recognit. 2007 Sep-Oct;20(5):405-15. doi: 10.1002/jmr.853.
10
Chemistry and molecular genetics of C1q.C1q的化学性质与分子遗传学
Behring Inst Mitt. 1989 Jul(84):8-19.

引用本文的文献

1
Proteins of the SubB family provide multiple mechanisms of serum resistance in .SubB家族的蛋白质在……中提供多种血清抗性机制。
Emerg Microbes Infect. 2025 Dec;14(1):2493926. doi: 10.1080/22221751.2025.2493926. Epub 2025 May 6.
2
Defining the Features of Complement-Active IgM.定义补体激活型IgM的特征。
J Mol Biol. 2025 Jun 15;437(12):169104. doi: 10.1016/j.jmb.2025.169104. Epub 2025 Mar 26.
3
Mucosal immune response in biology, disease prevention and treatment.生物学、疾病预防与治疗中的黏膜免疫反应。
Signal Transduct Target Ther. 2025 Jan 8;10(1):7. doi: 10.1038/s41392-024-02043-4.
4
The emerging role of Fusobacteria in carcinogenesis.梭杆菌属在致癌作用中的新作用。
Eur J Clin Invest. 2024 Dec;54 Suppl 2(Suppl 2):e14353. doi: 10.1111/eci.14353.
5
The evolution of flexibility and function in the Fc domains of IgM, IgY, and IgE.免疫球蛋白 M(IgM)、免疫球蛋白 Y(IgY)和免疫球蛋白 E(IgE)Fc 结构域的灵活性和功能的演变。
Front Immunol. 2024 Oct 9;15:1389494. doi: 10.3389/fimmu.2024.1389494. eCollection 2024.
6
Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics.六聚体和五聚体IgM与血清来源的C1q及重组C1q模拟物的相互作用研究
Life (Basel). 2024 May 17;14(5):638. doi: 10.3390/life14050638.
7
PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration.聚唾液酸纳米颗粒激活补体因子H介导的替代补体途径抑制作用:一种针对年龄相关性黄斑变性的更安全潜在疗法。
Pharmaceuticals (Basel). 2024 Apr 17;17(4):517. doi: 10.3390/ph17040517.
8
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques.人类和恒河猴补体介导免疫中的性别和物种相关差异。
mBio. 2024 Mar 13;15(3):e0028224. doi: 10.1128/mbio.00282-24. Epub 2024 Feb 22.
9
Complement component C1q is an immunological rheostat that regulates Fc:Fc[Formula: see text]R interactions.补体成分 C1q 是一种免疫变阻器,可调节 Fc:Fc[Formula: see text]R 相互作用。
Immunogenetics. 2023 Aug;75(4):369-383. doi: 10.1007/s00251-023-01311-x. Epub 2023 Jun 15.
10
Calreticulin Interferes with C1q-Mediated Complement Activation.钙网蛋白干扰C1q介导的补体激活。
Trop Med Infect Dis. 2023 Jan 7;8(1):47. doi: 10.3390/tropicalmed8010047.